No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
IMU Imugene Ltd
- 0.038
- +0.002+5.56%
20min DelayMarket Closed Dec 20 16:00 AET
287.55MMarket Cap-1.81P/E (Static)
0.038High0.036Low13.30MVolume0.036Open0.036Pre Close485.15KTurnover0.13052wk High0.21%Turnover Ratio7.57BShares0.03552wk Low-0.021EPS TTM237.60MFloat Cap38.521Historical HighLossP/E (Static)6.25BShs Float0.004Historical Low-0.021EPS LYR5.56%Amplitude--Dividend TTM2.38P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Imugene to Receive A$11 Million R&D Tax Refund for FY23 | ASX:IMU, OTC:IUGNF
6 ASX Shares Down 50%+ in 2024. Are They Cheap?
Imugene Doses First Patient in Intratumoral Injection Group of Phase 1 Cancer Trial
Five at Five AU: ASX to End Week on a High Note | ASX:IMU, OTC:IUGNF
Why Imugene, Neuren, Sigma, and Smartgroup Shares Are Charging Higher
Imugene Opens First Australian Site for Azer-cel Clinical Trial Targeting Lymphoma | ASX:IMU, OTC:IUGNF
Trending AU Stocks
ASX High Dividend ASX High Dividend
